Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.
- DOI
- 10.1111/j.1365-2265.2010.03827.x
- Published
- 2010 Sep
- Container
- Clinical endocrinology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/j.1365-2265.2010.03827.x,
title = {Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.},
author = {Tan T and Cabrita IZ and Hensman D and Grogono J and Dhillo WS and Baynes KC and Eliahoo J and Meeran K and Robinson S and Nihoyannopoulos P and Martin NM},
year = {2010},
journal = {Clinical endocrinology},
doi = {10.1111/j.1365-2265.2010.03827.x},
url = {https://doi.org/10.1111/j.1365-2265.2010.03827.x}
}RIS
TY - JOUR TI - Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia. AU - Tan T AU - Cabrita IZ AU - Hensman D AU - Grogono J AU - Dhillo WS AU - Baynes KC AU - Eliahoo J AU - Meeran K AU - Robinson S AU - Nihoyannopoulos P AU - Martin NM PY - 2010 JO - Clinical endocrinology DO - 10.1111/j.1365-2265.2010.03827.x UR - https://doi.org/10.1111/j.1365-2265.2010.03827.x ER -
APA
T, T., IZ, C., D, H., J, G., WS, D., KC, B., J, E., K, M., S, R., P, N., & NM, M. (2010). Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia.. Clinical endocrinology. https://doi.org/10.1111/j.1365-2265.2010.03827.x
Source records
- pubmed · retrieved 2026-09-25T18:55:19.709Z